Sunil Healthcare Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 396654, "name": "Sunil Healthcare", "stock_name": "Sunil Healthcare", "full_name": "Sunil Healthcare Ltd", "name_url": "stocks-analysis/sunil-healthcare", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "62.50", "chg": -0.73, "chgp": "-1.15%", "dir": -1, "prev_price": "63.23", "mcapval": "69.00 Cr", "mcap": "Micro Cap", "scripcode": 537253, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE671C01016", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "1.08 k", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sunil-healthcare-396654-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Sunil Healthcare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-3975719", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunilHealthcare_mojoScore_3975719.png", "date": "2026-05-05 10:10:34", "description": "Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Sunil Healthcare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-3960524", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SunilHealthcare_mojoScore_3960524.png", "date": "2026-04-24 10:10:43", "description": "Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 24 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Sunil Healthcare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-3944492", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SunilHealthcare_mojoScore_3944492.png", "date": "2026-04-13 10:10:45", "description": "Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 13 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Sunil Healthcare Ltd Falls to 52-Week Low of Rs 56.35 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/sunil-healthcare-ltd-stock-falls-to-52-week-low-of-rs5635-3935125", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SunilHealthcare_priceRelatedfactors_3935125.png", "date": "2026-04-07 09:36:09", "description": "For the second consecutive session, Sunil Healthcare Ltd has seen its share price decline sharply, hitting a fresh 52-week low of Rs 56.35 on 7 Apr 2026 despite opening the day with a gap-up. This renewed weakness comes amid heightened volatility and a broader market environment that has not favoured the stock’s micro-cap status." }, { "title": "Sunil Healthcare Ltd Falls 2.17%: Valuation Upgrade Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/sunil-healthcare-ltd-falls-217-valuation-upgrade-amidst-continued-downtrend-3932359", "imagepath": "", "date": "2026-04-04 17:10:46", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 30:</strong> Stock closes at Rs.61.97, down 1.01%</p>\n <p><strong>Apr 1:</strong> Stock declines further to Rs.61.00 (-1.57%)</p>\n <p><strong>Apr 2:</strong> New 52-week low of Rs.58.1 recorded amid volatility</p>\n <p><strong>Apr 2:</strong> Rating upgraded to 'Sell' by MarketsMOJO</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.62.60</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.61.24</div><div class=\"stat-change negat..." }, { "title": "Sunil Healthcare Ltd Falls to 52-Week Low of Rs 58.1 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/sunil-healthcare-ltd-falls-to-52-week-low-of-rs581-amid-continued-downtrend-3930575", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SunilHealthcare_priceRelatedfactors_3930575.png", "date": "2026-04-02 14:10:07", "description": "For the fourth consecutive session, Sunil Healthcare Ltd closed lower, culminating in a fresh 52-week low of Rs 58.1 on 2 Apr 2026. This decline comes despite an intraday high of Rs 64.5, reflecting significant volatility and persistent selling pressure." }, { "title": "Sunil Healthcare Ltd Rating Upgraded to Sell on Valuation and Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-rating-upgraded-to-sell-on-valuation-and-financial-trends-3929602", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SunilHealthcare_mojoScore_3929602.png", "date": "2026-04-02 08:11:23", "description": "Sunil Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026. This change reflects a nuanced improvement in valuation metrics and financial trends, despite ongoing challenges in quality and technical indicators. The company’s Mojo Score now stands at 32.0, signalling a cautious but more favourable outlook compared to its previous standing." }, { "title": "Sunil Healthcare Ltd Declines 1.94% Amid Valuation Upgrade and Persistent Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/sunil-healthcare-ltd-declines-194-amid-valuation-upgrade-and-persistent-downtrend-3922898", "imagepath": "", "date": "2026-03-29 11:00:55", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Mar:</strong> Stock hits 52-week low of Rs.60.66 amid sharp decline</p>\n <p><strong>17 Mar:</strong> Further 52-week low at Rs.58.61 despite intraday highs</p>\n <p><strong>19 Mar:</strong> Rating upgraded to Sell; stock closes at Rs.61.95</p>\n <p><strong>20 Mar:</strong> Stock rebounds to Rs.63.25, ending week with slight loss</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.64.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value..." }, { "title": "Sunil Healthcare Ltd Downgraded to Strong Sell Amid Mixed Financial and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-downgraded-to-strong-sell-amid-mixed-financial-and-valuation-signals-3909344", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunilHealthcare_mojoScore_3909344.png", "date": "2026-03-24 08:15:33", "description": "Sunil Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 23 March 2026, reflecting a complex interplay of valuation improvements, financial trends, quality concerns and technical indicators. Despite some positive quarterly results and an attractive valuation profile, the company’s weak long-term fundamentals and underperformance relative to the broader market have weighed heavily on investor sentiment." } ], "total": 118, "sid": "396654", "stock_news_url": "https://www.marketsmojo.com/news/sunil-healthcare-396654" }, "announcements": [ { "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A", "datetime": "24-Apr-2026", "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Sunil Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24302DL1973PLC189662</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>19.08</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BB+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: SATYENDU PATTNAIK <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: cs@sunilhealthcare.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: PAWAN RATHI <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: cfo@sunilhealthcare.com</div> </div> <div> <br/> Date: 24/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>", "source": "BSE" }, { "caption": "Compliance Certificate Under Regulation 40 (10) Of SEBI LODR For The Year Ended 31St March 2026", "datetime": "16-Apr-2026", "details": "Compliance Certificate under Regulation 40(10) of SBI LODR for the year ended 31st March 2026", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "07-Apr-2026", "details": "Compliance Certificate u/r 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st March 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 30: Stock closes at Rs.61.97, down 1.01%

Apr 1: Stock declines further to Rs.61.00 (-1.57%)

Apr 2: New 52-week low of Rs.58.1 recorded amid volatility

Apr 2: Rating upgraded to 'Sell' by MarketsMOJO

Read full news article

Sunil Healthcare Ltd Falls to 52-Week Low of Rs 58.1 as Sell-Off Deepens

2026-04-02 14:10:07

For the fourth consecutive session, Sunil Healthcare Ltd closed lower, culminating in a fresh 52-week low of Rs 58.1 on 2 Apr 2026. This decline comes despite an intraday high of Rs 64.5, reflecting significant volatility and persistent selling pressure.

Read full news article

Sunil Healthcare Ltd Rating Upgraded to Sell on Valuation and Financial Trends

2026-04-02 08:11:23

Sunil Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026. This change reflects a nuanced improvement in valuation metrics and financial trends, despite ongoing challenges in quality and technical indicators. The company’s Mojo Score now stands at 32.0, signalling a cautious but more favourable outlook compared to its previous standing.

Read full news article

Sunil Healthcare Ltd Declines 1.94% Amid Valuation Upgrade and Persistent Downtrend

2026-03-29 11:00:55

Key Events This Week

16 Mar: Stock hits 52-week low of Rs.60.66 amid sharp decline

17 Mar: Further 52-week low at Rs.58.61 despite intraday highs

19 Mar: Rating upgraded to Sell; stock closes at Rs.61.95

20 Mar: Stock rebounds to Rs.63.25, ending week with slight loss

Week Open

Rs.64.50

Week Close

Read full news article

Sunil Healthcare Ltd Downgraded to Strong Sell Amid Mixed Financial and Valuation Signals

2026-03-24 08:15:33

Sunil Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 23 March 2026, reflecting a complex interplay of valuation improvements, financial trends, quality concerns and technical indicators. Despite some positive quarterly results and an attractive valuation profile, the company’s weak long-term fundamentals and underperformance relative to the broader market have weighed heavily on investor sentiment.

Read full news article

View All News

Sr. No.	Particulars	Details
1	Name of Company	Sunil Healthcare Ltd
2	CIN NO.	L24302DL1973PLC189662
3	Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)	19.08
4	Highest Credit Rating during the previous FY	BB+
4a	Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)	CARE RATINGS LIMITED
5	Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework	BSE